Clinical trial

Positioning Imatinib for Pulmonary Arterial Hypertension

NCT04416750

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-01-20

PhasePHASE2

Study timeline

Study start (actual)2021-01-20Date precision: day

Registry last updated2023-10-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

Imatinib MesylateDRUG · verified · RxNorm: imatinib mesylate

Sponsors & collaborators

Imperial College Londonlead sponsor

National Institute for Health Research, United Kingdomcollaborator

Medical Research Councilcollaborator

University of Cambridgecollaborator

University of Sheffieldcollaborator

Mapped research locations

LondonUnited Kingdom1 CambridgeUnited Kingdom1 SheffieldUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04416750 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.